KAVL vs XXII vs TPVG vs GNLN vs CNTX

For growth investors, 22nd Century Group, Inc.

(XXII) is the stronger pick with 48. 1% revenue growth year-over-year, versus -99. 3% for Kaival Brands Innovations Group, Inc. (KAVL). TriplePoint Venture Growth BDC Corp. (TPVG) offers the better valuation at 4. 9x trailing P/E (6. 5x forward), making it the more compelling value choice. Analysts rate Context Therapeutics Inc. (CNTX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, TriplePoint Venture Growth BDC Corp.

(TPVG) delivered a total return of -13. 5%, compared to -100. 0% for 22nd Century Group, Inc. (XXII). Over 10 years, the gap is even starker: TPVG returned +93. 3% versus XXII's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Kaival Brands Innovations Group, Inc.

(KAVL) is the lower-risk stock at -0. 17β versus Greenlane Holdings, Inc. 's 2. 17β — meaning GNLN is approximately -1414% more volatile than KAVL relative to the S&P 500. On balance sheet safety, Context Therapeutics Inc. (CNTX) carries a lower debt/equity ratio of 0% versus 133% for TriplePoint Venture Growth BDC Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), 22nd Century Group, Inc.

(XXII) is pulling ahead at 48. 1% versus -99. 3% for Kaival Brands Innovations Group, Inc. (KAVL). On earnings-per-share growth, the picture is similar: 22nd Century Group, Inc. grew EPS 99. 9% year-over-year, compared to 6. 8% for Kaival Brands Innovations Group, Inc.. Over a 3-year CAGR, XXII leads at -24. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

TriplePoint Venture Growth BDC Corp.

(TPVG) is the more profitable company, earning 50. 6% net margin versus -356. 2% for Kaival Brands Innovations Group, Inc. — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus -365. 3% for KAVL. At the gross margin level — before operating expenses — KAVL leads at 1037%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for CNTX: 125.

3% to $5. 25.

In this comparison, KAVL (100.

0% yield), XXII (100. 0% yield), TPVG (17. 1% yield) pay a dividend. GNLN, CNTX do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Kaival Brands Innovations Group, Inc.

(KAVL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 17), 100. 0% yield). Greenlane Holdings, Inc. (GNLN) carries a higher beta of 2. 17 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KAVL: -100. 0%, GNLN: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (KAVL (Consumer Defensive) and XXII (Consumer Defensive) and TPVG (Financial Services) and GNLN (Consumer Defensive) and CNTX (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: KAVL is a small-cap income-oriented stock; XXII is a small-cap high-growth stock; TPVG is a small-cap high-growth stock; GNLN is a small-cap quality compounder stock; CNTX is a small-cap quality compounder stock. KAVL, XXII, TPVG pay a dividend while GNLN, CNTX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.